MTP-101-C
- Generic Name
- MTP-101-C
Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Immune-mediated Colitis (IMC)
Phase 2
Recruiting
- Conditions
- Immune-mediated Colitis (IMC)Immune-related Dermatitis
- Interventions
- First Posted Date
- 2024-07-15
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Diwakar Davar
- Target Recruit Count
- 30
- Registration Number
- NCT06499896
- Locations
- 🇺🇸
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath